Biote (BTMD) Cash from Financing Activities (2021 - 2026)

Biote (BTMD) has reported Cash from Financing Activities for 6 consecutive years, with -$21.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 854.32% year-over-year to -$21.5 million; the TTM figure through Mar 2026 stood at -$62.8 million (up 13.84% YoY), while the FY2025 annual figure was -$43.6 million, up 42.75% from the prior year.
• Cash from Financing Activities came in at -$21.5 million for Q1 2026 at Biote, down from -$9.1 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $84.3 million in Q2 2022, with the low at -$59.0 million in Q2 2024.
• Average Cash from Financing Activities over 5 years is -$5.4 million, with a median of -$5.1 million recorded in 2023.
• Across the five-year window, Cash from Financing Activities jumped 125.57% in 2022 and plunged 1065.92% in 2024, its largest moves.
• Year by year, Cash from Financing Activities stood at -$4.0 million in 2022, then jumped by 36.49% to -$2.5 million in 2023, then plunged by 293.43% to -$9.9 million in 2024, then grew by 8.08% to -$9.1 million in 2025, then sank by 135.89% to -$21.5 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$21.5 million, -$9.1 million, and -$4.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.